| Literature DB >> 30963053 |
Harim Tavares Dos Santos1, John Lennon Silva Cunha2, Lucas Alves Mota Santana1, Cleverson Luciano Trento1, Antônio Carlos Marquetti1, Ricardo Luiz Cavalcanti de Albuquerque-Júnior2, Sílvia Ferreira de Sousa3.
Abstract
Plasma cell cheilitis (PCC) is an inflammatory disorder of unknown etiology that affects the lip. It is characterized histologically by a dense infiltrate of plasma cells with a variety of clinical features. The response to different therapeutic modalities is controversial, especially regarding the effectiveness of corticosteroids. We present a case of a 56-year-old Caucasian man with a painful ulcerated and crusted area in the lower lip, resembling a squamous cell carcinoma or actinic cheilitis. Topical corticosteroid was used for one week, which resulted in partial regression and motivated a biopsy. The histological examination provided the diagnosis of PCC. The patient has been disease-free for six months. We also provide a discussion on the criteria of differential diagnosis and management of this rare condition.Entities:
Keywords: Cheilitis; Lip; Lip diseases; Plasma cell
Year: 2019 PMID: 30963053 PMCID: PMC6433141 DOI: 10.4322/acr.2018.075
Source DB: PubMed Journal: Autops Case Rep ISSN: 2236-1960
Figure 1Clinical aspect of lips. A – Absence of upper lip changes; B – Well-marked ulcerated and crusted area on the lower lip.
Figure 2Photomicrograph of the biopsy specimen. A – Hyperplastic and parakeratinized stratified squamous epithelium with dense infiltrate of plasma cells in the lamina propria (Hematoxylin-eosin, 20X); B – Presence of a band-like infiltrate of plasma cells. (Hematoxylin-eosin, 100X); C – Monomorphic mature plasma cells. (Hematoxylin-eosin, 400X); D – Presence of Russel body (arrow) (Hematoxylin-eosin, 200X).
Figure 3Photomicrograph of the biopsy specimen. Plasma cells showing positivity for both lambda (A) and kappa (B) (Immunohistochemistry, 200X).
Figure 4Clinical aspect of lower lip during follow-up. A, B – Complete regression of ulcerated and bleeding area 35 days after the biopsy.